CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right_256_384.jpg)
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
AAT is a substantial socio-economic burden to livestock farmers in Sub-Saharan Africa, affecting and killing millions of cattle every year
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Subscribe To Our Newsletter & Stay Updated
